Century Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $109,164 | $4,173 | $791 |
Gross Profit | -3,201 | 109,164 | 4,173 | 791 |
EBITDA | -31,463 | 77,397 | -30,979 | -27,936 |
EBIT | -34,664 | 74,176 | -34,297 | -31,234 |
Net Income | -32,541 | 76,560 | -36,073 | -31,226 |
Net Change In Cash | 0 | 109,164 | 4,173 | 791 |
Free Cash Flow | -27,909 | -34,623 | -24,377 | -27,528 |
Cash | 56,878 | 51,865 | 58,441 | 52,593 |
Basic Shares | 86,238 | 86,098 | 78,648 | 84,704 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $6,589 | $2,235 | $5,199 | $1,058 |
Gross Profit | 6,589 | 2,235 | -4,872 | -4,582 |
EBITDA | -111,472 | -121,208 | -119,340 | -89,924 |
EBIT | -124,776 | -134,252 | -129,411 | -94,506 |
Net Income | -126,566 | -136,673 | -130,932 | -95,824 |
Net Change In Cash | 6,589 | 2,235 | 5,199 | 1,058 |
Cost of Revenue | 28,082 | 30,434 | ||
Free Cash Flow | -110,289 | -102,084 | -16,552 | -133,972 |
Cash | 58,441 | 47,324 | 84,265 | 56,445 |
Basic Shares | 78,648 | 59,314 | 57,755 | 55,005 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.38 |
2025-03-31 | $0.89 |
2024-12-31 | -$0.41 |
